Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)
Year: 2024
Type: article
Source: Eye
Authors: Ashish Sharma, Peter K. Kaiser, Ramin Tadayoni, Frank G. Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, Taku Wakabayashi, Se Joon Woo, David Sarraf, Nilesh Kumar, Nikulaa Parachuri, Carl D. Regillo, Kourous A. Rezaei, Arshad M. Khanani, Francesco Bandello, Mahesh Shanamugam, Lalit Verma, Mangat Ram Dogra, Muralidhar NS, Manisha Agarwal, Anat Loewenstein, Baruch D. Kuppermann, International Retina Biosimilar Study Group (Inter BIOS Group), Giuseppe Querques, Jay Sheth, Seemantini Ayachit, Chitaranjan Mishra, Debdulal Chakraborty, Alay Banker, Şengül Özdek, Kodjikian Laurent, Alper Bilgic, Paolo Lanzetta, Caroline Baumal, Nancy Holekemp, Taiji Sakamoto, Adnan Tufail, Nicolas Yannuzzi, Giulia Corradetti, David Boyer, Aleksandra Rachitskaya, Tunde Peto, Maximilian W. M. Wintergerst, Valentina Sarao, Barbara Parolini, Prithvi Mruthyunjaya, Quan Dong Nguyen, Diana V. Do, Pearse A. Keane, Tarek Hassan, Jayanth Sridhar, David Eichenbaum, Dilraj S. Grewal, Francesc March de Ribot, Martin Splitzer, Martin S. Zinkernagel, Tomoko Ueda-Consolvo, Masaaki Ishida, Tomoko Nakamura, Shuichiro Yanagisawa, Kotaro Tsuboi, Atsushi Hayashi, Assaf Hilely, Dinah Zur
Institutions: Cleveland Clinic, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, University of Bonn, Moorfields Eye Hospital NHS Foundation Trust, Moorfields Eye Hospital, Kingston Hospital NHS Trust, Kingston Hospital, NIHR Moorfields Biomedical Research Centre, University College London, Thomas Jefferson University, Mid Atlantic Retina, Wills Eye Hospital, Seoul National University, Seoul National University Bundang Hospital, University of California, Los Angeles, Madhavi Netralaya, Sankara Eye Hospital, Coimbatore, Illinois Retina Associates, University of Nevada, Reno, Sierra Eye Associates, Vita-Salute San Raffaele University, Sankara Eye Hospital, Bangalore, Centre for Sight, Grewal Eye Institute, Dr. Shroff’s Charity Eye Hospital, Tel Aviv University, University of California, Irvine, Gazi University, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Centre National de la Recherche Scientifique, Université de Lyon, Matériaux Ingénierie et Science, Institut National des Sciences Appliquées de Lyon, University of Udine, Tufts University, Roche (Switzerland), Kagoshima University, University of Miami, Doheny Eye Institute, Retina Vitreous Associates Medical Group, Queen's University Belfast, University Hospital Bonn, Stanford University, Associated Retinal Consultants, Oakland University, Beaumont Hospital, Royal Oak, Retina Vitreous Associates of Florida, Duke University, Duke Medical Center, Universitat de Girona, University Medical Center Hamburg-Eppendorf, University of Otago, University of Bern, University Hospital of Bern, University of Toyama, Aichi Medical University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Funders: Research to Prevent Blindness, Amgen, Biogen, Alexion Pharmaceuticals, Regeneron Pharmaceuticals, Galecto, Innovent Biologics, Alimera Sciences, NGM Biopharmaceuticals, Omeros Corporation, Apellis Pharmaceuticals, Carl Zeiss Meditec AG, Santen, Heidelberg Engineering, Genentech, Samsung, Allergan, University of California, Irvine, Japan Society for the Promotion of Science, Janssen Pharmaceuticals
OpenAlex ID: W4401882384